Bait Bakfar Ltd (TLV:BKFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,490.00
-6.00 (-0.40%)
Dec 4, 2025, 5:24 PM IDT
Bait Bakfar Revenue
Bait Bakfar had revenue of 27.67M ILS in the quarter ending September 30, 2025, with 5.87% growth. This brings the company's revenue in the last twelve months to 107.78M, up 5.59% year-over-year. In the year 2024, Bait Bakfar had annual revenue of 103.40M with 4.34% growth.
Revenue (ttm)
107.78M
Revenue Growth
+5.59%
P/S Ratio
9.65
Revenue / Employee
474.80K
Employees
227
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103.40M | 4.30M | 4.34% |
| Dec 31, 2023 | 99.10M | 6.11M | 6.58% |
| Dec 31, 2022 | 92.99M | 7.60M | 8.90% |
| Dec 31, 2021 | 85.39M | 944.00K | 1.12% |
| Dec 31, 2020 | 84.45M | -404.00K | -0.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 915.05M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 162.56M |